Skip to content

ResMed RMD EV / sales

EV / sales at other companies

Eli Lilly logo
Eli LillyLLY
11.9×-4.0×
Solventum logo
SolventumSOLV
-0.5×
Stryker logo
StrykerSYK
5.4×-1.3×
Baxter International logo
Baxter InternationalBAX
0.6×-0.8×
Insmed logo
InsmedINSM
43×+4.8×
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
2.1×-0.3×

Other financials

Income statement

See full
Revenue$1.4B+10.8%
Gross profit$891.0M+16.3%
Operating income$499.8M+17.3%
Net income$398.7M+9.2%
EPS (diluted)$2.74+10.5%

Balance sheet

See full
Cash & equivalents$1.7B+78.0%
Total debt$1.1B+29.8%
Total equity$6.5B+17.1%
Total assets$8.8B+16.1%

Cash flow

See full
Operating cash flow$554.1M-4.2%
CapEx$33.7M+61.8%
Free cash flow$520.5M-6.7%

Valuation

See full
Market cap$27.36B-0.5%
Enterprise value$26.8B-2.0%
P/E18×-2.9×
P/S4.9×-0.5×

Profitability

See full
Gross margin61.6%+2.8pp
Operating margin34.2%+2.1pp
Net margin27.4%+1.3pp
FCF margin31.7%+0.4pp

Returns & leverage

See full
Return on equity25.2%-0.6pp
Debt / equity0.2×0.0×
Current ratio-0.4×

Where this comes from

Calculated from ResMed’s reported figures.

Based on the most recent quarter.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ResMed's EV / sales?
ResMed (RMD) reported EV / sales of 5.8× in Q1 2026.
How has ResMed's EV / sales changed year-over-year?
ResMed's EV / sales decreased by 11.1% year-over-year, from 6.5× to 5.8×.
What is the long-term trend for ResMed's EV / sales?
Over 4 years (2021 to 2025), ResMed's EV / sales has grown at a -10.8% compound annual growth rate (CAGR), from 11.4× to 7.2×.
What does EV / sales mean?
What the whole business costs relative to its annual sales.
How do you interpret EV / sales?
A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
How does EV / sales compare across companies?
Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.